Research Use Only — All products are research reference standards for in-vitro laboratory use only. Not for human consumption, veterinary use, or therapeutic application. Full Disclaimer
Sale!

CJC-1295 (C₁₅₂H₂₅₂N₄₄O₄₂, 29aa, CAS 863288-34-0) + Ipamorelin (C₃₈H₄₉N₉O₅, 5aa, CAS 170851-70-4). Synthetic peptide blend studied at GHRH-R + GHS-R1a in receptor-binding and combined-pathway in-vitro signaling research. ≥99% purity, lyophilized. Research use only. Not for human consumption.

Specifications
Formula C₁₅₂H₂₅₂N₄₄O₄₂
Mol. Wt. 3,367.97 Da
CAS 863288-34-0
GHS-R / GHRH-R Ligand RUO

CJC-1295 (No DAC) + Ipamorelin

For Research Use Only — Not for Human Consumption

Synthetic peptide blend studied at GHRH-R + GHS-R1a in receptor-binding and combined-pathway in-vitro signaling…

$52.00
$44.20

Title Range Discount
Bulk Discount 3 - 5 5%
Bulk Discount 6 - 10 10%
>11 Bulk Discount 11 + 15%
Free Shipping on All Orders $300+
Shipping protection on every order — covers loss or damage in transit. Learn more →

Buy more, save more: 5% off at 3+ · 10% off at 6+ · 15% off at 11+. Applied automatically at checkout.

Certificate of Analysis preview
Certificate of Analysis
Lot 04/23/2026 · purity confirmed by HPLC
View COA (PDF)
  • Lab-grade COA
  • 99%+ purity
  • 24-hour shipping
  • Refund-backed
RUO

For research use only. Not for human consumption. All products are sold strictly as reference standards for in-vitro laboratory research and are not intended to diagnose, treat, cure, or prevent any disease.

Description

CJC-1295 + Ipamorelin is a synthetic peptide blend combining two complementary research compounds. CJC-1295 (Modified GRF 1-29) is a 29-amino acid DPP-IV-resistant peptide on the GHRH backbone (MW ~3,367.97 Da, CAS 863288-34-0, molecular formula C₁₅₂H₂₅₂N₄₄O₄₂) that binds at GHRH-R with downstream cAMP/PKA signaling in research models. Ipamorelin is a selective pentapeptide that binds at GHS-R1a (MW ~711.85 Da, CAS 170851-70-4, molecular formula C₃₈H₄₉N₉O₅) with minimal cortisol, prolactin, or aldosterone response in cellular assays.

This blend is utilized to study the combined effects of concurrent GHRH-R and GHS-R1a pathway engagement on somatotroph cell function in research models, hypothalamic–pituitary in-vitro signaling, and receptor cross-talk mechanisms.

Supplied as a lyophilized powder with ≥99% purity verified by HPLC. For storage and handling conditions, refer to the Certificate of Analysis provided with each lot. This product is intended strictly for laboratory research use only (RUO) and is not for human consumption, therapeutic use, or any diagnostic purposes.

Third-Party Lab Analysis

Every batch is independently tested by a USA-based, ISO/IEC 17025-accredited third-party laboratory. Download or preview the Certificate of Analysis for each lot below.

10mg

Lot: PP412-26-001Tested: 04/23/2026
Download

Your browser can't display the PDF inline. Download the COA instead.

Additional information

Vial Size

10mg

0